Jennifer K. Moses - 14 Jul 2021 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Lara Meisner, Attorney-in-Fact for Jennifer K. Moses
Issuer symbol
VRDN
Transactions as of
14 Jul 2021
Net transactions value
$0
Form type
4
Filing time
15 Jul 2021, 16:24:38 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 14 Jul 2021 Common Stock 25,000 $17.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vest monthly over a three year period, subject to Reporting Person's continued service on the Board.